30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Matthew Lipman

Track

Insider profile

Currently holds positions in Soluna Holdings Inc and Capstone Therapeutics Corp

Positions

Position Company Period
Director Soluna Holdings Inc Oct. 21, 2016 -
Director Capstone Therapeutics Corp July 14, 2017 -
Matthew Lipman's trades of Soluna Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-10 2024-12-09
S Sale
73,000 +18.1%
143.90
US$568,599 		73,000 +18.1% 143.90 US$568,599
2024-12-10 2024-12-06
S Sale
13,147 +13.5%
56.11
US$452,846 		13,147 +13.5% 56.11 US$452,846
2024-12-10 2024-12-06
S Sale
35,735 +30.0%
55.95
US$2,362,734 		35,735 +30.0% 55.95 US$2,362,734
2024-11-12 2024-11-11
PlS Planned sale
9,080 -100.0%
4.00
US$36,320 		9,080 -100.0% 4.00 US$36,320
2024-11-12 2024-11-08
PlS Planned sale
21,900 -70.7%
3.42
US$74,898 		21,900 -70.7% 3.42 US$74,898
2024-11-07 2024-11-07
PlS Planned sale
24,420 -44.1%
3.59
US$87,668 		24,420 -44.1% 3.59 US$87,668
2024-11-07 2024-11-06
PlS Planned sale
23,700 -30.0%
3.56
US$84,372 		23,700 -30.0% 3.56 US$84,372
2024-11-07 2024-11-05
PlS Planned sale
11,000 -12.2%
3.23
US$35,530 		11,000 -12.2% 3.23 US$35,530
2025-03-28 2024-11-04
PlS Planned sale
20,600 -18.6%
3.11
US$64,066 		20,600 -18.6% 3.11 US$64,066
2025-03-28 2024-11-01
PlS Planned sale
31,300 -22.0%
3.39
US$106,107 		31,300 -22.0% 3.39 US$106,107
2025-03-28 2024-10-31
PlS Planned sale
8,000 -5.3%
3.44
US$27,520 		8,000 -5.3% 3.44 US$27,520